title: Intralesional vinblastine injections for treatment of classic Kaposi sarcoma in diabetic patients.
abstract: Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.
authors.affiliation: Department of Clinical-Surgical, Diagnostic, and Pediatric Science, Institute of Dermatology, Fondazione IRCCS Policlinico San Matteo, Viale Camillo Golgi 19, 27100 Pavia, Italy. cvassallo@yahoo.com.
authors.forename: Camilla
authors.initials: C
authors.lastname: Vassallo
authors.forename: Andrea
authors.initials: A
authors.lastname: Carugno
authors.forename: Federica
authors.initials: F
authors.lastname: Derlino
authors.forename: Olga
authors.initials: O
authors.lastname: Ciocca
authors.forename: Valeria
authors.initials: V
authors.lastname: Brazzelli
authors.forename: Giovanni
authors.initials: G
authors.lastname: Borroni
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D012514:Sarcoma, Kaposi / Q000150:complications / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage*
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine